The loss of erection can be attributed to various factors such as high blood pressure, aging, diabetes mellitus, smoking, alcoholism, depression, nerve or spinal cord damage, and low testosterone levels.
In terms of geography, the Americas dominated the global erectile dysfunction market and is expected to hold close to 50% of the market share.
Market Analysis and Insights: Global Erectile Dysfunction Devices Market
The global Erectile Dysfunction Devices market was valued at US$ 1458.4 in 2020 and will reach US$ 1988.2 million by the end of 2027, growing at a CAGR of 5.3% during 2022-2027.
Global Erectile Dysfunction Devices Scope and Market Size
The global Erectile Dysfunction Devices market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Erectile Dysfunction Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Inflatable Penile Implant
Semi-Rigid Rod Implant
Segment by Application
Congenital Patients
Pathological Patients
The Erectile Dysfunction Devices market is analysed and market size information is provided by regions (countries). Segment by Application, the Erectile Dysfunction Devices market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Eli Lilly
Pfizer
Bayer
Boston Scientific
Coloplast
Apricus Biosciences
Cristalia Produtos Quimicos Farmaceuticos
Dong-A Socio
Endo Pharmaceuticals
Futura Medical
Meda Pharmaceuticals
Promedon
SK Chemical
Teva Pharmaceuticals
Vivus
Zephyr Surgical Implants (ZSI)
In terms of geography, the Americas dominated the global erectile dysfunction market and is expected to hold close to 50% of the market share.
Market Analysis and Insights: Global Erectile Dysfunction Devices Market
The global Erectile Dysfunction Devices market was valued at US$ 1458.4 in 2020 and will reach US$ 1988.2 million by the end of 2027, growing at a CAGR of 5.3% during 2022-2027.
Global Erectile Dysfunction Devices Scope and Market Size
The global Erectile Dysfunction Devices market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Erectile Dysfunction Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Inflatable Penile Implant
Semi-Rigid Rod Implant
Segment by Application
Congenital Patients
Pathological Patients
The Erectile Dysfunction Devices market is analysed and market size information is provided by regions (countries). Segment by Application, the Erectile Dysfunction Devices market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Eli Lilly
Pfizer
Bayer
Boston Scientific
Coloplast
Apricus Biosciences
Cristalia Produtos Quimicos Farmaceuticos
Dong-A Socio
Endo Pharmaceuticals
Futura Medical
Meda Pharmaceuticals
Promedon
SK Chemical
Teva Pharmaceuticals
Vivus
Zephyr Surgical Implants (ZSI)
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.